In a filing, MaxCyte Inc revealed its Chief Commercial Officer Soleymannezhad Ali unloaded Company’s shares for reported $3850.0 on Mar 18 ’25. In the deal valued at $3.18 per share,1,211 shares were sold. As a result of this transaction, Soleymannezhad Ali now holds 59,439 shares worth roughly $0.16 million.
Then, Sandoval David I. sold 353 shares, generating $1,122 in total proceeds. Upon selling the shares at $3.18, the GENERAL COUNSEL now owns 64,219 shares.
Before that, Swirsky Douglas J sold 6,939 shares. MaxCyte Inc shares valued at $22,061 were divested by the CHIEF FINANCIAL OFFICER at a price of $3.18 per share. As a result of the transaction, Swirsky Douglas J now holds 111,811 shares, worth roughly $0.31 million.
Craig Hallum initiated its MaxCyte Inc [MXCT] rating to a Buy in a research note published on November 29, 2023; the price target was $7. William Blair began covering MXCT with “an Outperform” recommendation on August 24, 2021. Wedbush started covering the stock on August 24, 2021. It rated MXCT as “an Outperform”.
Price Performance Review of MXCT
On Monday, MaxCyte Inc [NASDAQ:MXCT] saw its stock unchanged to $2.73. Over the last five days, the stock has lost -13.33%. MaxCyte Inc shares have fallen nearly -34.37% since the year began. Nevertheless, the stocks have fallen -36.81% over the past one year. While a 52-week high of $5.26 was reached on 01/21/25, a 52-week low of $2.70 was recorded on 03/31/25. SMA at 50 days reached $3.83, while 200 days put it at $4.00.
Levels Of Support And Resistance For MXCT Stock
The 24-hour chart illustrates a support level at 2.64, which if violated will result in even more drops to 2.56. On the upside, there is a resistance level at 2.79. A further resistance level may holdings at 2.86. The Relative Strength Index (RSI) on the 14-day chart is 27.94, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.29, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.51%. Stochastics %K at 10.92% indicates the stock is a buying.
How much short interest is there in MaxCyte Inc?
A steep rise in short interest was recorded in MaxCyte Inc stocks on 2025-03-14, growing by 0.21 million shares to a total of 2.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 2.77 million shares. There was a rise of 6.89%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 24, 2021 when Stifel began covering the stock and recommended ‘”a Buy”‘ rating along with a $18 price target.
